News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,536 Results
Type
Article (44653)
Company Profile (440)
Press Release (680442)
Multimedia
Podcasts (95)
Webinars (16)
Section
Business (209554)
Career Advice (2528)
Deals (36176)
Drug Delivery (107)
Drug Development (84054)
Employer Resources (176)
FDA (16574)
Job Trends (15243)
News (354858)
Policy (33420)
Tag
Academia (2686)
Accelerated approval (12)
Adcomms (27)
Allergies (99)
Alliances (51248)
ALS (116)
Alzheimer's disease (1508)
Antibody-drug conjugate (ADC) (169)
Approvals (16548)
Artificial intelligence (332)
Autoimmune disease (33)
Automation (19)
Bankruptcy (375)
Best Places to Work (11904)
BIOSECURE Act (19)
Biosimilars (124)
Biotechnology (331)
Bladder cancer (98)
Brain cancer (36)
Breast cancer (376)
Cancer (2973)
Cardiovascular disease (228)
Career advice (2119)
Career pathing (32)
CAR-T (195)
CDC (32)
Cell therapy (529)
Cervical cancer (22)
Clinical research (68924)
Collaboration (1068)
Company closure (3)
Compensation (699)
Complete response letters (29)
COVID-19 (2732)
CRISPR (66)
C-suite (343)
Cystic fibrosis (119)
Data (3054)
Decentralized trials (2)
Denatured (31)
Depression (72)
Diabetes (352)
Diagnostics (6507)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (147)
Drug pricing (133)
Drug shortages (30)
Duchenne muscular dystrophy (134)
Earnings (88840)
Editorial (45)
Employer branding (22)
Employer resources (152)
Events (117632)
Executive appointments (874)
FDA (18256)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (976)
Gene editing (143)
Generative AI (23)
Gene therapy (409)
GLP-1 (850)
Government (4646)
Grass and pollen (4)
Guidances (181)
Healthcare (19302)
HIV (42)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (164)
Immuno-oncology (9)
Indications (40)
Infectious disease (2909)
Inflammatory bowel disease (157)
Inflation Reduction Act (13)
Influenza (64)
Intellectual property (122)
Interviews (462)
IPO (16917)
IRA (47)
Job creations (3758)
Job search strategy (1769)
Kidney cancer (13)
Labor market (52)
Layoffs (532)
Leadership (21)
Legal (8067)
Liver cancer (82)
Longevity (11)
Lung cancer (417)
Lymphoma (212)
Machine learning (11)
Management (58)
Manufacturing (405)
MASH (94)
Medical device (13657)
Medtech (13662)
Mergers & acquisitions (19979)
Metabolic disorders (893)
Multiple sclerosis (99)
NASH (19)
Neurodegenerative disease (130)
Neuropsychiatric disorders (39)
Neuroscience (2232)
NextGen: Class of 2025 (6853)
Non-profit (4632)
Now hiring (48)
Obesity (457)
Opinion (256)
Ovarian cancer (103)
Pain (115)
Pancreatic cancer (121)
Parkinson's disease (194)
Partnered (22)
Patents (303)
Patient recruitment (170)
Peanut (52)
People (59341)
Pharmaceutical (87)
Pharmacy benefit managers (22)
Phase I (21647)
Phase II (30403)
Phase III (22492)
Pipeline (1667)
Policy (213)
Postmarket research (2621)
Preclinical (9311)
Press Release (67)
Prostate cancer (147)
Psychedelics (44)
Radiopharmaceuticals (272)
Rare diseases (494)
Real estate (6067)
Recruiting (69)
Regulatory (23287)
Reports (50)
Research institute (2446)
Resumes & cover letters (407)
Rett syndrome (9)
RNA editing (10)
RSV (49)
Schizophrenia (94)
Series A (169)
Series B (116)
Service/supplier (11)
Sickle cell disease (67)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3795)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (61)
The Weekly (62)
Vaccines (815)
Venture capital (56)
Weight loss (283)
Women's health (49)
Worklife (18)
Date
Today (95)
Last 7 days (370)
Last 30 days (1887)
Last 365 days (32072)
2025 (17323)
2024 (36383)
2023 (41108)
2022 (52384)
2021 (56911)
2020 (55111)
2019 (47750)
2018 (36013)
2017 (33260)
2016 (32661)
2015 (38674)
2014 (32426)
2013 (27384)
2012 (29478)
2011 (30128)
2010 (28244)
Location
Africa (810)
Alabama (67)
Alaska (7)
Arizona (253)
Arkansas (14)
Asia (39997)
Australia (6703)
California (7609)
Canada (2379)
China (696)
Colorado (328)
Connecticut (333)
Delaware (195)
Europe (87743)
Florida (1126)
Georgia (250)
Hawaii (1)
Idaho (60)
Illinois (661)
India (28)
Indiana (365)
Iowa (18)
Japan (233)
Kansas (112)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1048)
Massachusetts (5754)
Michigan (248)
Minnesota (459)
Mississippi (3)
Missouri (91)
Montana (30)
Nebraska (25)
Nevada (81)
New Hampshire (70)
New Jersey (2125)
New Mexico (30)
New York (2125)
North Carolina (1152)
North Dakota (9)
Northern California (3324)
Ohio (239)
Oklahoma (16)
Oregon (38)
Pennsylvania (1631)
Puerto Rico (17)
Rhode Island (37)
South America (1182)
South Carolina (34)
South Dakota (1)
Southern California (2836)
Tennessee (126)
Texas (1149)
United States (28318)
Utah (223)
Virginia (192)
Washington D.C. (74)
Washington State (658)
West Virginia (4)
Wisconsin (70)
725,536 Results for "good therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
April 1, 2025
·
4 min read
Mergers & acquisitions
Sage’s Story Comes to ‘Good End’ With Up To $795M Acquisition by Supernus
Stifel analysts said the deal “feels like an unremarkable outcome for a company that was once one of the hottest stories in CNS.” Supernus’ offer beats Biogen’s unsolicited bid of about $7.22 per share, which arrived with a thud in late January.
June 16, 2025
·
2 min read
·
Annalee Armstrong
Career Advice
11 Signs of Good Company Culture
Good company culture is a crucial aspect of professional life. Look at these 11 important indications of good workplace culture before accepting a job offer or use them to evaluate your new employer.
September 19, 2024
·
4 min read
·
Editorial Staff
Press Releases
Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin
March 20, 2025
·
5 min read
Tariffs
Roche in ‘Very, Very Good Position’ To Weather Trump Tariffs but M&A May Suffer
Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., according to CEO Thomas Schinecker, who declined to reveal what these assets are.
April 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
July 3, 2025
·
7 min read
Drug pricing
‘Finally, Some Good News’: Trump Signals Support for Removing IRA’s Pill Penalty
Analysts are “cautiously optimistic” about Trump’s executive order, noting that changes to the IRA drug price negotiation program will still require Congressional action before being implemented.
April 16, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Healthcare at a Crossroads: Maintaining Good Science in Uncertain Times
Continuing our SCOPE 2025 coverage, Rohit Nambisan, CEO at Lokavant addresses not only current challenges, but the life sciences industry’s responsibility to maintain scientific integrity.
February 17, 2025
·
1 min read
·
Lori Ellis
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Manufacturing
Pfizer Prepared to Reshore Manufacturing if Trump Makes Good on Tariff Threats
Last week, Eli Lilly also responded to the President’s tariff warnings by investing $27 billion to construct four manufacturing facilities across the U.S. in five years.
March 4, 2025
·
2 min read
·
Tristan Manalac
1 of 72,554
Next
